Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Innexus Biotechnology Inc IXSBF

Healthcare Biotechnology
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.


GREY:IXSBF - Post by User

Innexus Biotechnology Inc > Geez ....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by ACE75on Jul 24, 2019 5:28pm
145 Views
Post# 29956684

RE:RE:RE:RE:RE:RE:Geez ....

RE:RE:RE:RE:RE:RE:Geez .... No sure what's going on with this company. Last I can remember they where at a criss road of making a promising cure for cancer. All of a sudden the owner and his son die in a plane crash and everything just disappeared over night. For something so valuable why wasn't it developed to its full potential.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities